Research on the Correlation Between Organoid Drug Sensitivity Testing and Precise Treatment of Gastrointestinal Tumors

NCT06332716 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

68

Enrollment

OTHER

Sponsor class

Conditions

Gastrointestinal Tumors，3D Organoids，Drug Sensitivity

Interventions

OTHER: Based on diagnostic and treatment guidelines/expert consensus, as well as clinical treatment experience, it is recommended that no more than 9 drugs be used for drug sensitivity testing each time.

Sponsor

Jianjun Yang,MD